Valuation: UCB

Market Cap 4.63TCr 5.29TCr 4.3TCr 3.95TCr 7.45TCr 5,10100Cr 7.55TCr 51TCr 20TCr 2,49600Cr 20TCr 19TCr 8,62200Cr P/E 2026 *
26.1x
P/E 2027 * 20.7x
Enterprise Value 4.61TCr 5.26TCr 4.28TCr 3.93TCr 7.41TCr 5,07400Cr 7.52TCr 51TCr 20TCr 2,48300Cr 20TCr 19TCr 8,57700Cr EV / Sales 2026 *
5.39x
EV / Sales 2027 * 4.56x
Free-Float
61.59%
Yield 2026 *
0.6%
Yield 2027 * 0.62%
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 59 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 5.3TCr
-3.56%-0.75%+19.37%-11.36% 6.87TCr
-1.65%+37.20%+37.20%+37.20% 4.36TCr
-2.83%-4.08%-53.81%-55.84% 4.07TCr
-2.67%+3.02%+61.18%-28.55% 3TCr
-2.67%-13.89%+87.50%-54.07% 2.37TCr
-1.36%+0.79%+71.85%+80.50% 2.35TCr
+0.11%+2.44%+4.06%+181.25% 2.05TCr
-0.39%+2.03%+72.19%+122.26% 1.67TCr
+0.25%-1.70%+80.09%+142.19% 1.62TCr
Average -1.43%-0.58%+42.18%+45.95% 3.15TCr
Weighted average by Cap. -1.77%+0.04%+31.51%+22.44%

Financials

2026 *2027 *
Net sales 854.34Cr 975.05Cr 793.13Cr 728.81Cr 1.37TCr 94TCr 1.39TCr 9.45TCr 3.7TCr 46TCr 3.66TCr 3.58TCr 1,59000Cr 964.37Cr 1.1TCr 895.27Cr 822.68Cr 1.55TCr 1,06200Cr 1.57TCr 11TCr 4.17TCr 52TCr 4.13TCr 4.04TCr 1,79500Cr
Net income 177.01Cr 202.01Cr 164.32Cr 151Cr 284.53Cr 19TCr 288.72Cr 1.96TCr 766.18Cr 9.54TCr 758.34Cr 742Cr 33TCr 227.71Cr 259.89Cr 211.4Cr 194.26Cr 366.04Cr 25TCr 371.43Cr 2.52TCr 985.67Cr 12TCr 975.59Cr 954.56Cr 42TCr
Net Debt -24Cr -28Cr -22Cr -21Cr -39Cr -2.67TCr -40Cr -267.87Cr -104.84Cr -1.31TCr -103.77Cr -101.53Cr -4.51TCr -232.32Cr -265.15Cr -215.68Cr -198.19Cr -373.45Cr -26TCr -378.95Cr -2.57TCr -1.01TCr -13TCr -995.34Cr -973.89Cr -43TCr
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA